Label: SCANTILY PAD- acne treatment liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 30, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Salicylic acid 1% ...........Acne Treatment

  • PURPOSE

    For the treatment of ACNE

  • WARNINGS

    WARNINGS For external use only. Skin
    irritation and dryness is more likely to
    occur when using this product if you use
    another topical acne medication at the
    same time. If irritation occurs, only use
    one topical acne medication at a time.

  • INDICATIONS & USAGE

    For the treatment of Acne

  • INACTIVE INGREDIENT

    INACTIVE INGREDIENTS Organic Aloe vera, organic
    grain alcohol, cocamidopropyl dimethylamine, SE
    Microbiome ComplexTM, sodium hydroxide, organic
    lemon essential oil.

  • DOSAGE & ADMINISTRATION

    DIRECTIONS Cleanse the skin. Use one pad to apply a
    thin layer of solution to affected areas. Start with one
    application daily, then increase to two times per day
    (morning and evening). If dryness or peeling occurs,
    reduce application to once a day or every other day.
    Test on a small area of skin before applying to face. If
    eye contact occurs, flush thoroughly with water.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children

  • PRINCIPAL DISPLAY PANEL

    Label

  • INGREDIENTS AND APPEARANCE
    SCANTILY PAD 
    acne treatment liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81953-100
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.01 mg  in 1 mg
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R) 0.8 mg  in 1 mg
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:81953-100-0150 mg in 1 JAR; Type 0: Not a Combination Product06/01/2021
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00606/01/2021
    Labeler - Dermala Inc (079278092)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!